Top 5 Biotechnology Angel Investors in Australia (June 2026)

Mike Wallas - Advisory Board @ Optifire Pty Ltd

Investment focus

Industry: Video, Water, Biotechnology
Stage:Seed
Geography: Australia

Investor stats

Total investments: 3
Lead/follow: 0% lead, 100% follow

Portfolio highlights

PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.

Show all investments...

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Investment focus

Industry: Health Care, Medical Device, Biotechnology
Stage:Series A, Seed
Geography: Australia, United States, The Netherlands

Investor stats

Total investments: 9
Round size: Series A $2.4M–$8.8M
Lead/follow: 11% lead, 89% follow

Portfolio highlights

Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.

Show all investments...

Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.

Investment focus

Industry: Medical, Health Care, Biotechnology
Stage:Seed, Pre-Seed
Geography: Canada, Australia

Investor stats

Total investments: 2
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.

Show all investments...

Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.

Investment focus

Industry: SaaS, Software, Health Care
Stage:Seed, Series A, Series B
Geography: Australia, Canada

Investor stats

Total investments: 8
Round size: Seed $740k–$808k; Series A $6.5M–$11M; Series B $5M–$8.8M
Lead/follow: 50% lead, 50% follow

Portfolio highlights

Ento — Ento was founded in Australia in 2009 and provides one platform for HR, WFM and engagement. Since then we’ve become the chosen solution for over 3,000 workplaces across retail, hospitality, health, community, and more; rostering more than 30 million shifts for businesses ranging in size from 10 to 2,000+ staff.Our software is part of the nextgeneration of workforce management tools; cloud-based, accessible via a smartphone, tablet or desktop, and integrated with leading ATS, POS and payroll systems to provide a complete solution.
Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
Kismet — Find the best disability or healthcare service to support your journey

Show all investments...